EasyManua.ls Logo

i-SENS Nipro Premier alpha - Performance Characteristics; Accuracy and Precision Studies (Continued); Interferences in Measurement; Interfering Substances Analysis

i-SENS Nipro Premier alpha
33 pages
To Next Page IconTo Next Page
To Next Page IconTo Next Page
To Previous Page IconTo Previous Page
To Previous Page IconTo Previous Page
Loading...
56 57
Within ± 0.83 mmol/L and Within ± 15%
599/600 (99.8%)
System accuracy results for glucose concentrations between
2.1 mmol/L and 29.5 mmol/L
Packed Cell Volume (Hematocrit)
The hematocrit levels (15 ~ 65%) were tested to evaluate the effect
of hematocrit level on measurement of glucose concentration.
Difference Averages
NO Interferent
1 Ascorbic acid -0.1 mmol/L 0.0 %
2 Bilirubin 0.1 mmol/L 1.3 %
3 EDTA 0.1 mmol/L 1.4 %
4 Fructose 0.1 mmol/L -0.3 %
5 Galactose -0.1 mmol/L -0.2 %
6 Haparin -0.04 mmol/L -0.8 %
7 Maltose -0.1 mmol/L -1.4 %
8 Maltotriose -0.03 mmol/L -0.1 %
9 Maltotetraose 0.02 mmol/L -0.7 %
10 Mannose -0.1 mmol/L 3.5 %
11 Xylose 1.9 mmol/L 8.9 %
12 2-deoxyglucose 0.1 mmol/L 0.2 %
13 Acetaminophen -0.1 mmol/L 2.7 %
14 Cholesterol 0.04 mmol/L -0.3 %
15 Creatinine 0.01 mmol/L -1.9 %
16 D,L-arabinose 0.1 mmol/L 3.1 %
Interval 1 Interval 2
2.8–5.5 mmol/L
13.9–19.4 mmol/L
Interferences
The effect of various interfering substances was evaluated in
whole blood samples on glucose measurements.
Within Run Precision
*Bloodav 2.1 mmol/L SD = 0.1 mmol/L
*Bloodav 4.2 mmol/L SD = 0.1 mmol/L
*Bloodav 7.2 mmol/L CV = 3.4%
*Bloodav 11.4 mmol/L CV = 3.2%
*Bloodav 17.9 mmol/L CV = 3.0%
Precision: The precision studies were performed in a laboratory
using Nipro Premier alpha BGM Systems.
Between Run Precision
*Controlav 2.2 mmol/L SD = 0.1 mmol/L
*Controlav 6.4 mmol/L CV = 2.9%
*Controlav 19.3 mmol/L CV = 3.0%
This study shows that there could be variation of up to 3.2%.
1.7 to 2.8 -0.3 to 0.4 mmol/L
5.3 to 8.0 -7.9 to 6.0%
15.5 to 23.3 -8.9 to 5.9%
Range (mmol/L)
Average of difference (Hct 15–65%)

Related product manuals